Back
Vertex Pharmaceuticals Stock Predictions
Sponsored
VRTX
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
VRTX
Vertex Pharmaceuticals
Last Price:
464.85
Seasonality Move:
-0.92%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Vertex Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 28.3% based on the past 33 years of stock performance.
- Vertex Pharmaceuticals has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Vertex Pharmaceuticals Stock Undervalued?
The current Vertex Pharmaceuticals [VRTX] share price is $464.92. The Score for VRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal. - VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Vertex Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 28.3% based on the past 33 years of stock performance.
Vertex Pharmaceuticals Stock Rating
Buy
53
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals overpriced?
- Vertex Pharmaceuticals has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Vertex Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com
52-Week Data
52-Week High:
510.64
52-Week Low:
341.85
Prediction Charts
Market Cap:
120B
Price in USD:
464.92
Volume:
1.39M
Beta:
0.95
Technical Analysis
SMA50:
482.49
SMA100:
468.90
SMA200:
440.47
52-Wk Change:
31.96%
Stock Predictions
-
Is Vertex Pharmaceuticals stock public?
Yes, Vertex Pharmaceuticals is a publicly traded company. -
What is the Vertex Pharmaceuticals stock quote today?
The Vertex Pharmaceuticals stock price is 464.92 USD today. -
How to buy Vertex Pharmaceuticals stock online?
You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-3 | 492.65 | 475.70 | 493.00 | 474.58 |
Sep-4 | 476.82 | 478.57 | 480.14 | 472.83 |
Sep-5 | 477.73 | 468.57 | 477.73 | 463.41 |
Sep-6 | 467.92 | 467.99 | 471.89 | 463.04 |
Sep-9 | 472.23 | 471.11 | 473.68 | 468.97 |
Sep-10 | 471.53 | 470.78 | 473.11 | 466.03 |
Sep-11 | 469.07 | 474.65 | 476.11 | 460.69 |
Sep-12 | 474.74 | 478.65 | 479.51 | 468.46 |
Sep-13 | 480.00 | 485.37 | 486.06 | 478.75 |
Sep-16 | 490.00 | 489.43 | 490.15 | 483.95 |
Sep-17 | 486.42 | 481.26 | 487.23 | 477.17 |
Sep-18 | 483.78 | 474.16 | 483.78 | 473.75 |
Sep-19 | 477.70 | 477.89 | 483.98 | 476.27 |
Sep-20 | 474.36 | 464.92 | 474.93 | 463.81 |
Vertex Pharmaceuticals Earnings
Vertex Pharmaceuticals Earnings Report: Per Share Vertex Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vertex Pharmaceuticals Forecast Revenue Growth
Vertex Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $1.22 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.